Cargando…
Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
Despite advances in the management of non-small cell lung cancer, it remains to be the leading cause of cancer-related deaths worldwide primarily because of diagnosis at a late stage with an overall 5-year survival rate of 17%. A reduction in mortality was achieved by low-dose computed tomography sc...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602468/ https://www.ncbi.nlm.nih.gov/pubmed/28979144 http://dx.doi.org/10.2147/OTT.S142149 |